UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 2, 2024
Accession Number:
0001213900-24-028970
Submission Type:
POS AM
CIK:
0001937993
Company Name:
Cadrenal Therapeutics, Inc.
File Number:
333-273384